Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 7pcd.1

HER2 IN COMPLEX WITH A COVALENT INHIBITOR

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.77 Å
Oligo State
monomer
Ligands
1 x 70I: 1-[4-[4-[[3,5-bis(chloranyl)-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]amino]pyrimido[5,4-d]pyrimidin-6-yl]piperazin-1-yl]-4-(3-fluoranylazetidin-1-yl)butan-1-one(Covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Wilding, B. et al., Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling. Nat Cancer (2022)
Release Date
2022-07-27
Peptides
Receptor tyrosine-protein kinase erbB-2: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Receptor tyrosine-protein kinase erbB-2